AstraZeneca Says Datopotamab Deruxtecan Combined With Imfinzi Shows High Disease Control Rates
By Anthony O. Goriainoff AstraZeneca and Daiichi Sankyo said that datopotamab deruxtecan, a cancer drug, combined with the Imfinzi cancer treatment--with or...
Source: marketwatch.com